{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T04:05:30Z","timestamp":1770523530867,"version":"3.49.0"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T00:00:00Z","timestamp":1732233600000},"content-version":"am","delay-in-days":357,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"NHLBI","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vascular Pharmacology"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.vph.2023.107243","type":"journal-article","created":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T00:31:36Z","timestamp":1700008296000},"page":"107243","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Myocardial infarction with non-obstructive coronary arteries: Diagnostic work-up, risk stratification and tailored therapies"],"prefix":"10.1016","volume":"153","author":[{"given":"C. Noel","family":"Bairey Merz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martha","family":"Gulati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vph.2023.107243_bb0005","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1161\/CIRCULATIONAHA.117.027666","article-title":"Myocardial infarction with nonobstructive coronary arteries (MINOCA)","volume":"135","author":"Pasupathy","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2023.107243_bb0010","doi-asserted-by":"crossref","first-page":"e618","DOI":"10.1161\/CIR.0000000000000617","article-title":"Fourth universal definition of myocardial infarction (2018)","volume":"138","author":"Thygesen","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2023.107243_bb0015","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1161\/CIRCULATIONAHA.111.026542","article-title":"Mechanisms of myocardial infarction in women without angiographically obstructive coronary artery disease","volume":"124","author":"Reynolds","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2023.107243_bb0020","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/clc.22894","article-title":"Why names matter for women: MINOCA\/INOCA (myocardial infarction\/ischemia and no obstructive coronary artery disease)","volume":"41","author":"Pacheco Claudio","year":"2018","journal-title":"Clin. Cardiol."},{"key":"10.1016\/j.vph.2023.107243_bb0025","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1161\/CIRCULATIONAHA.117.031999","article-title":"Myocardial scar is prevalent and associated with subclinical myocardial dysfunction in women with suspected ischemia but no obstructive coronary artery disease","volume":"137","author":"Wei","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2023.107243_bb0030","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/0002-9149(94)90739-0","article-title":"Clinical and arteriographic characterization of patients with unstable angina without critical coronary arterial narrowing (from the TIMI-IIIA trial)","volume":"74","author":"Diver","year":"1994","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.vph.2023.107243_bb0035","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1161\/CIRCINTERVENTIONS.113.000606","article-title":"Prognosis of patients with non-ST-segment-elevation myocardial infarction and nonobstructive coronary artery disease: propensity-matched analysis from the acute catheterization and urgent intervention triage strategy trial","volume":"7","author":"Planer","year":"2014","journal-title":"Circ. Cardiovasc. Interv."},{"key":"10.1016\/j.vph.2023.107243_bb0040","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1001\/archinte.166.13.1391","article-title":"Unanswered questions for management of acute coronary syndrome: risk stratification of patients with minimal disease or normal findings on coronary angiography","volume":"166","author":"Bugiardini","year":"2006","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.vph.2023.107243_bb0045","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.ahj.2006.02.035","volume":"152","author":"Patel","year":"2006","journal-title":"Am. Heart J."},{"key":"10.1016\/j.vph.2023.107243_bb0050","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1161\/CIRCULATIONAHA.114.011201","article-title":"Systematic review of patients presenting with suspected myocardial infarction and nonobstructive coronary arteries","volume":"131","author":"Pasupathy","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2023.107243_bb0055","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1136\/heartjnl-2020-318045","article-title":"Antiplatelet therapy in patients with myocardial infarction without obstructive coronary artery disease","volume":"107","author":"Bossard","year":"2021","journal-title":"Heart"},{"key":"10.1016\/j.vph.2023.107243_bb0060","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ahj.2020.10.059","article-title":"Randomized evaluation of beta blocker and ACE-inhibitor\/angiotensin receptor blocker treatment in patients with myocardial infarction with non-obstructive coronary arteries (MINOCA-BAT): rationale and design","volume":"231","author":"Nordenskjold","year":"2021","journal-title":"Am. Heart J."},{"key":"10.1016\/j.vph.2023.107243_bb0065","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1161\/CIRCULATIONAHA.116.026336","article-title":"Medical therapy for secondary prevention and long-term outcome in patients with myocardial infarction with nonobstructive coronary artery disease","volume":"135","author":"Lindahl","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2023.107243_bb0070","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1093\/cvr\/cvaa006","article-title":"Treatment of coronary microvascular dysfunction","volume":"116","author":"Bairey Merz","year":"2020","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.vph.2023.107243_bb0075","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1177\/1741826711398430","article-title":"Effects of statins on coronary and peripheral endothelial function in humans: a systematic review and meta-analysis of randomized controlled trials","volume":"18","author":"Reriani","year":"2011","journal-title":"Eur. J. Cardiovasc. Prev. Rehabil."},{"key":"10.1016\/j.vph.2023.107243_bb0080","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ahj.2021.03.011","article-title":"Rationale and design of the Women\u2019s ischemia trial to reduce events in nonobstructive CAD (WARRIOR) trial","volume":"237","author":"Handberg","year":"2021","journal-title":"Am. Heart J."},{"key":"10.1016\/j.vph.2023.107243_bb0085","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ahj.2018.03.010","article-title":"Rationale and design of the British Heart Foundation (BHF) coronary microvascular angina (CorMicA) stratified medicine clinical trial","volume":"201","author":"Ford","year":"2018","journal-title":"Am. Heart J."}],"container-title":["Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189123001039?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189123001039?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T07:02:32Z","timestamp":1724655752000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1537189123001039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":17,"alternative-id":["S1537189123001039"],"URL":"https:\/\/doi.org\/10.1016\/j.vph.2023.107243","relation":{},"ISSN":["1537-1891"],"issn-type":[{"value":"1537-1891","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Myocardial infarction with non-obstructive coronary arteries: Diagnostic work-up, risk stratification and tailored therapies","name":"articletitle","label":"Article Title"},{"value":"Vascular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vph.2023.107243","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107243"}}